GXO Logistics Inc vs Koninklijke Philips NV — how do they compare? GXO Logistics Inc trades at $46.63 (market cap $5.32B), while Koninklijke Philips NV trades at $24.22 (market cap $23.52B). The key difference: Koninklijke Philips NV is far larger — about 4.4× GXO Logistics Inc's market cap, and Koninklijke Philips NV pays a 4.17% dividend while GXO Logistics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold GXO Logistics Inc for 28 Days and Koninklijke Philips NV for 84 Days on average.
| GXO | PHG | |
|---|---|---|
Market Cap | $5.32B | $23.52B |
Volume | 1,255,816 | 1,635,069 |
Sector | Industrials | Health |
52-Week High | $65.59 | $32.91 |
52-Week Low | $44.17 | $23.81 |
Typical Hold Time | 28 Days | 84 Days |
Enterprise Value | $10.67B | $29.87B |
Dividend Yield | — | 4.17% |
Signals from Pluang's Aura AI — not financial advice
GXO trades at $46.56, up 1.24% today, with a neutral technical signal and bearish moving average trend. The company reported Q2 2026 EPS of $0.59, beating estimates, and maintains strong analyst support with an 88.89% buy rating. Recent news highlights strategic partnerships with Columbia Sportswear and expansion in aerospace & defense, signaling growth initiatives. Revenue for 2025 was $13.18 billion, with a net income margin of 0.96%, though profitability remains modest.
The outlook is positive, driven by analyst consensus price target of $66.67 and improving industry prospects. Key opportunities include operational efficiency gains from new labor management systems and sector tailwinds. Risks involve stagnant margins and competitive pressures, requiring close monitoring of execution on growth targets to justify current valuations.
PHG trades at $24.24, up 0.62% today, amid a bearish technical signal from moving averages. The company has beaten EPS estimates for three consecutive quarters, with Q3 2026 results pending. Recent financials show a return to profitability in 2025 with net income of $895 million, while cash flow from operations remains positive at $1.17 billion. Key developments include new product launches in healthcare imaging and a $33.7 million ARPA-H award for AI-enabled stroke care.
The outlook is mixed: strong earnings momentum and solid profitability metrics support upside, but technical weakness and a high 'Hold' analyst consensus suggest near-term caution. Risks include competitive pressures and debt levels, though institutional buying activity indicates underlying confidence.
Trailing returns across standard periods
Latest headlines on both assets
GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →